Please login to the form below

Not currently logged in


This page shows the latest Pipeline news and features for those working in and with pharma, biotech and healthcare.

Daily brief: Novartis spends big on ezcema,

Daily brief: Novartis spends big on ezcema,

Novartis already has ZPL389 in its pipeline, a phase II ezcema treatment it gained with the acquisition of Ziarco two years ago. ... The company, based in London and New York, has four ongoing clinical programmes, one compassionate use programme and a

Latest news

More from news
Approximately 16 fully matching, plus 1,081 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 122 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 175 partially matching documents found.

Latest from PMHub

  • Training the next generation of biotech leaders

    It would be nice to think that in the next ten to fifteen years, we’ ll see a pipeline of new medicines emerging off the back of these early successes, like

  • Rapid Payer Response Early Pipeline Case Study

    Rapid Payer Response Early Pipeline Case Study. Downloads. . ... RPR Early Pipeline Case Study.

  • Market Access Transformation

    Market Access Transformation. MAT offers an online, information exchange called Rapid Payer Response that allows healthcare stakeholders to secure immediate, global, expert insight and feedback from the largest and most diverse online payer resource

  • Alzheimer’s disease: reviewing the immediate treatment horizon

    However, the learnings from these ‘ failures’ have paved the way for the robust pipeline of treatments that could potentially be coming to market in the next five years. ... We can see this reflected in the five-year Phase 3 pipeline, where  Aβ

  • Infographic: RA Perceptions

    Findings from a recent survey of physicians across Europe has revealed that, despite stiff competition from newer biologics, biosimilars and pipeline agents, physicians expect current market leaders Enbrel (etanercept) and Humira ... Less than 25% of

More from PMHub
Approximately 1 fully matching, plus 34 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....